3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
9
Breast Neoplasms
7
Neoplasms
5
Colorectal Neoplasms
5
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Melanoma
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Depression
2
Anxiety Disorders
2
Alzheimer Disease
2
Advanced Malignant Solid Neoplasm
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tobacco Smoking
1
Testicular Neoplasms
1
Spondylitis, Ankylosing
1
Specific Learning Disorder
1
Smoking Cessation
1
Smoking
1
Signs and Symptoms
1
Sedentary Behavior
1
Rectal Neoplasms
1
Psoriasis
1
Pancreatic Diseases
1
Pancreatic Cyst
1
Interventions
Surveys and Questionnaires
2
Saline Solution
2
Exercise
2
siltuximab
1
pegfilgrastim
1
oxycodone-acetaminophen
1
erenumab
1
Xylitol
1
Triamcinolone Acetonide
1
Triamcinolone
1
Transcranial Direct Current Stimulation
1
Touch
1
Telemedicine
1
Standard of Care
1
Remifentanil
1
Oxycodone
1
Myofascial Release Therapy
1
Morphine
1
Methods
1
Methadone
1
Mastectomy
1
Laughter Therapy
1
Kyphoplasty
1
Ketorolac Tromethamine
1
Ketorolac
1
Fluorouracil
1
Duloxetine Hydrochloride
1
Dronabinol
1
Curettage
1
Caregivers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pain
×
Methods
×
Clear all
NCT07332377
2026-03-18
PsyMINT
Virginia Commonwealth University
Phase NA
Recruiting
25 enrolled